DYEE Capital (德屹资本) is a venture capital and private equity firm founded in 2016 and headquartered in Xiamen, China, with a branch in Shanghai. The firm invests across a diversified range of industries including healthcare, consumer discretionary, financial services, information technology, and TMT, focusing on venture and growth opportunities.
54% of their portfolio is in Biotech & Life Sciences. They made 1 investment in the last 12 months. Average disclosed round size is $63.1M (across 10 rounds with reported amounts).
Portfolio
9
Fund Size
—
Top Stage
Series A
Last 12 Mo
1
Team
DZ
Dezhen Zhu
Founder, Chairman and Managing Partner
SC
Swing Chen
Partner
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
13 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 BridGene | Series B | $28M | Jan 2026 |
 WeLion | Series D | — | Nov 2022 |
 Degron Therapeutics | Series A | $22M | Jun 2022 |
| GGenFleet | Series C | $75M | Dec 2021 |
| IIONOVA Life Science | Unknown | $100M | Aug 2021 |
 Elpiscience | Series C | $105M | May 2021 |
| WeLion | Series A | — | Jan 2021 |
| IInventisBio | Series D | $147M | Sep 2020 |
| Elpiscience | Series B | $100M | Dec 2019 |
 Ionova | Series A | $17M | Oct 2019 |
| Ionova | Series A | $17M | Jan 2019 |
| Elpiscience | Series A | $20M | Dec 2018 |
| 发发网 | Series C | — | Jan 2018 |
Top Co-Investors
LAV7 shared
Hillhouse Investment4 shared
CDH Investments4 shared
Cormorant Asset Management3 shared
Oriza3 shared
Baidu Ventures2 shared
Parkway Venture Capital2 shared
IDG Capital2 shared
GLP2 shared
China Merchants Group2 shared
Xiaomi2 shared
Shenzhen Capital Group1 shared
Next Capital1 shared
Med-Fine Capital1 shared
Icon Ventures1 shared
YuanBio Venture Capital1 shared
HighLight Capital1 shared
Lake Bleu Capital1 shared
Aurora Venture Investments1 shared
Last updated: 20 October 2026